Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
52,085,929
-
Share change
-
-1,274,763
-
Total reported value
-
$5,676,848,580
-
Put/Call ratio
-
169%
-
Price per share
-
$109.03
-
Number of holders
-
287
-
Value change
-
-$158,899,374
-
Number of buys
-
128
-
Number of sells
-
185
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2016
As of 31 Dec 2016,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
287 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,085,929 shares.
The largest 10 holders included
PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, CADIAN CAPITAL MANAGEMENT, LP, Bank of New York Mellon Corp, WESTFIELD CAPITAL MANAGEMENT CO LP, FIL Ltd, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A..
This page lists
288
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.